A seris of coorta carcinomas (n = 49) resected from patients with known chinical outcomes were analysed for E-caderin expression using in situ hybridisation to measure mRNA. Patients surviving 5 years or longer (n = 31) exhibited significantly higher kvels of E-cadherin mRNA than those surviving less than 5 years (n = 18, P = 0.003). These peiminary reslts from this small sample suggest that E-cadherin expression may be a useful prognostic marker in colorectal cancer patients.
Colorectal cancer is one of the most common malignances in the developed world and remains a major publc health problem (King's Fund Forum, 1990 ). Pathological staging, using the Dukes claation, offers an accurate guide to the outcome of patients who have undergone surgicl resection (Deans et al., 1992 (Deans et al., , 1993 . However, in Dukes stage B category, many patients who putatively have had a curative resection will succumb to metastasis or tumour recurr. Identification of the lily prognostic outcome of any one individual within this broad division would be of great use but unfortunately remains impossible at this time.
E-cadherin is a member of the large cadherin family of homophilic cell-cell adhesion molecules and is expressed in all epithelial tissues (Takeichi, 1990 ). E-cadherin moleules maintain intercellular connections and, importantly, participate in signalling and communication between neighbouring cells (Takeichi, 1990) . Tbere is increasing evience that E-cadherin plays a significant role in neoplastic behaviour. For example, experimental studies have revealed that loss of this mokcule from epithelial cells is associated with the acquisition of the invasive phenotype (Vlminckx et al., 1991 ). There appears, moreover, to be a quantitative correlation between the level of E-cadherin expression and invasive ability in a range of cell lines derived from human carcinomas (Frixen et al., 1991) . A large number of fresh human cancers also have been analysed for E-cadherin expression by immunohistochemistry (Takeichi, 1993) , including clinical material denved from patients with colorectal cancer (Dorudi et al., 1993; Kinsella et al., 1993; Nigam et al., 1993) .
Generally, these investigations have revealed an inverse relationship between E-cadherin expression and tumour grade, with poorly differentiated tumours exhibiting reduced or absent immunoreactivity (Takeichi, 1993) . Although downregulation of E-cadherin has been observed in undifferentiated (Dorudi et al., 1993; Kinsella et al., 1993; Nigam et al., 1993) and advanced colorectal carcinomas (Dorudi et al., 1993) , no study has yet examined the possible relationship between expression of this cell adhesion molecule and prognosis in colorectal cancer. Such a relationship, however, has been exaied in three other tumour types: bladder, head and neck and gastric cancer (Brnguier et al., 1993; Mattijsen et al., 1993; Mayer et al., 1993) . Uniformly, these authors all reported that a reduced level of E-cadherin was correlated significntly with poor prognosis, but the studies all used frozen material for E-cadherin immunohistochemistry, tended not to have stage-matched material and had lmited follow-up data (of less than 5 years) (Bringuier et al., 1993; Mattijsen et al., 1993; Mayer et al., 1993) .
Previously we showed that in colorectal cancer there is a good correlation between the presence of E-cadherin mRNA and protein (Dorudi et al., 1993 3+  3+  3+  3+  3+  3+  3+  3+  2+  3+  3+  3+  3+  2+  3+  3+  3+  3+ Mod, moderately differentiated. immunoreactivity in human carcinomas, but only three were performed using paraffin-embedded material (Dorudi el al., 1993; Moll et al., 1993; Rasbridge et al., 1993) ; the remainder all used frozen tumours (see Takeichi 1993 for review). This has made it difficult to examine the majority of archival material. As stringent fixation requirements are necessary for consistent and reliable E-cadherin immunohistochemistry in paraffin-embedded tumours (Rasbridge et al., 1993) It may well be of interest that four of the five poorly differentiated tumours examined in this study which displayed E-cadherin scores of 3+ were derived from patients surviving in excess of 5 years. This is particularly true since high tumour grade is known to be associated with reduced survival in colorectal cancer (Deans et al., 1993) , while poorly differentiated bowel carcinomas generally exhibit reduced or absent E-cadherin expression (Dorudi et al., 1993; Kinsella et al., 1993; Nigam et al., 1993) .
It is apparent from our results that low or absent Ecadherin expression is associated with reduced survival in patients undergoing curative resections for Dukes stage B colorectal carcinomas. However, the numbers in this study are still small and the analysis retrospective. A large prospective study is necessary before it can be ascertained whether levels of E-cadherin expression in colorectal tumours can truly yield independent prognostic information. If these preliminary findings are confirmed in a prospective study, they would be of considerable clinical relevance as, at present, accurate prediction of the risk of recurrence or metastasis in patients with Dukes stage B cancers is not possible (Morson, 1990) . Clearly, such information would be extremely valuable in designating these patients to protocols of adjuvant therapy and might aid in an understanding of the molecular nature of tumour spread.
